These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25394415)

  • 1. Decreased tumorigenesis in mice with a Kras point mutation at C118.
    Huang L; Carney J; Cardona DM; Counter CM
    Nat Commun; 2014 Nov; 5():5410. PubMed ID: 25394415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced HRAS G12V-Driven Tumorigenesis of Cell Lines Expressing KRAS C118S.
    Huang L; Counter CM
    PLoS One; 2015; 10(4):e0123918. PubMed ID: 25902334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoform-Specific Effects of Wild-Type Ras Genes on Carcinogen-Induced Lung Tumorigenesis in Mice.
    Weyandt JD; Carney JM; Pavlisko EN; Xu M; Counter CM
    PLoS One; 2016; 11(12):e0167205. PubMed ID: 27911940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rare codons capacitate Kras-driven de novo tumorigenesis.
    Pershing NL; Lampson BL; Belsky JA; Kaltenbrun E; MacAlpine DM; Counter CM
    J Clin Invest; 2015 Jan; 125(1):222-33. PubMed ID: 25437878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
    Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
    Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-canonical genomic driver mutations of urethane carcinogenesis.
    Li S; Counter CM
    PLoS One; 2022; 17(4):e0267147. PubMed ID: 35482806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
    To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
    Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors.
    Manenti G; Trincucci G; Pettinicchio A; Amendola E; Scarfò M; Dragani TA
    Oncogene; 2008 Sep; 27(43):5753-8. PubMed ID: 18560355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating The Role Of Nitric Oxide Synthase In Oncogenic Ras-Driven Tumorigenesis.
    Counter C
    Redox Biol; 2015 Aug; 5():417. PubMed ID: 28162280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
    To MD; Wong CE; Karnezis AN; Del Rosario R; Di Lauro R; Balmain A
    Nat Genet; 2008 Oct; 40(10):1240-4. PubMed ID: 18758463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Kras mutant fraction in the lung DNA of mice exposed to aerosolized particulate vanadium pentoxide by inhalation.
    Banda M; McKim KL; Haber LT; MacGregor JA; Gollapudi BB; Parsons BL
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():53-60. PubMed ID: 26232258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis.
    Minowada G; Miller YE
    Am J Respir Cell Mol Biol; 2009 Jan; 40(1):31-7. PubMed ID: 18635814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer.
    Weyandt J
    Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin drives KRAS-mutant lung adenocarcinoma.
    Giopanou I; Kanellakis NI; Giannou AD; Lilis I; Marazioti A; Spella M; Papaleonidopoulos V; Simoes DCM; Zazara DE; Agalioti T; Moschos C; Magkouta S; Kalomenidis I; Panoutsakopoulou V; Lamort AS; Stathopoulos GT; Psallidas I
    Carcinogenesis; 2020 Aug; 41(8):1134-1144. PubMed ID: 31740923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capturing the primordial Kras mutation initiating urethane carcinogenesis.
    Li S; MacAlpine DM; Counter CM
    Nat Commun; 2020 Apr; 11(1):1800. PubMed ID: 32286309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.
    Weyandt JD; Lampson BL; Tang S; Mastrodomenico M; Cardona DM; Counter CM
    PLoS One; 2015; 10(10):e0140253. PubMed ID: 26452271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
    Green S; Trejo CL; McMahon M
    Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity.
    Adhikari H; Kattan WE; Kumar S; Zhou P; Hancock JF; Counter CM
    Nat Commun; 2021 Sep; 12(1):5248. PubMed ID: 34504076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis.
    Le Roux Ö; Pershing NLK; Kaltenbrun E; Newman NJ; Everitt JI; Baldelli E; Pierobon M; Petricoin EF; Counter CM
    Elife; 2022 Sep; 11():. PubMed ID: 36069770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kirsten Ras* oncogene: significance of its discovery in human cancer research.
    Tsuchida N; Murugan AK; Grieco M
    Oncotarget; 2016 Jul; 7(29):46717-46733. PubMed ID: 27102293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.